Investing.com72d agobearish
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrastNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.74d agobearish
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech SlipsBarrons.com76d agoneutral
Moderna Is Betting Big on Its Cancer Vaccine. This Is What Wall Street Wants to See.The Wall Street Journal77d agoneutral
Hype for Moderna’s Cancer Vaccine Is Running Ahead of the MathThe Wall Street Journal78d agobullish
Investors Thought Moderna Was Left for Dead. Then Came a Cancer Breakthrough.The Wall Street Journal79d agoneutral
How a Big Bet on Cancer Vaccines Brought Moderna Back from the BrinkKiplinger79d agoneutral
Dow Adds 517 Points Ahead of Nvidia Earnings Week: Stock Market TodayInvestor's Business Daily79d agoneutral
Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into Biotech